# A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients

> **NCT06133010** · PHASE2 · WITHDRAWN · sponsor: **ModernaTX, Inc.**

## Conditions studied

- Cytomegalovirus Infection

## Interventions

- **BIOLOGICAL:** mRNA-1647
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06133010
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-02-08
- **Primary completion:** 2027-02-14
- **Final completion:** 2027-12-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Trial was cancelled by Sponsor
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06133010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06133010, "A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06133010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*